Document is current

Any future updates will be listed below

Current vaccine technology with an emphasis on recombinant measles virus as a new perspective for vaccination against SARS-CoV-2

Crossref DOI link: https://doi.org/10.1007/s41207-021-00263-6

Published Online: 2021-07-04

Published Print: 2021-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark